Why study design matters more than results
A result is only as meaningful as the study design that produced it. A 30% body weight reduction in lean mice given high doses by injection tells you something different from a 30% body weight reduction in obese humans in a randomised controlled trial. Both are results. They are not equally meaningful for understanding whether a compound works in humans.
Understanding basic study design elements allows you to place any result in its proper context before drawing conclusions.
The hierarchy of evidence
Research findings are generally ranked by how well a study design controls for confounding factors - things other than the compound being studied that might explain the result.
In vitro studies (cell culture): The lowest level of clinical translation. Cells in a dish behave differently from cells in a living organism with circadian rhythms, immune systems, and dozens of interacting metabolic pathways. Many compounds look promising in cell culture and fail in animals.
Animal studies: More informative than cell culture because they involve a complete organism. However, rodent physiology differs from human physiology in important ways, and dosing in rodents often does not translate directly to humans. Most peptide research is at this stage.
Human case reports and case series: Observations in individual people or small groups. Useful for generating hypotheses but cannot establish causation - many other factors could explain the outcome.
Observational studies in humans: Study groups of people and measure associations. Can establish correlation but not causation. Confounding factors are a persistent problem.
Randomised controlled trials (RCTs): Participants are randomly assigned to receive the compound or a control (placebo or comparator). This randomisation is the only method that controls for unknown confounders. RCTs are the gold standard for establishing efficacy.
Meta-analyses and systematic reviews: Systematically combine multiple studies to estimate overall effect size. Quality depends entirely on the quality and consistency of the underlying studies.
Key questions to ask about any peptide study
What model was used? In vitro, animal (which species), or human?
What was the dose and route? A dose effective subcutaneously in rats may be impractical or irrelevant in humans. Very high doses in animals can produce effects that would never be achievable safely in humans.
Was there a control group? Without a comparison group, it is impossible to know whether the outcome was caused by the compound or something else (time, other interventions, placebo effect).
Was it randomised and blinded? Randomisation prevents selection bias. Blinding prevents expectation bias from influencing outcomes.
Who funded the study? Industry-funded studies are not automatically invalid, but funding source is relevant context. Independent replication is the check on any result, regardless of funder.
Has it been replicated? A single study - regardless of how well designed - is not sufficient to establish a finding. Replication by independent groups is the mechanism by which scientific findings are verified.
Red flags in peptide marketing
Certain patterns in how research is presented should prompt skepticism:
- Citing animal or cell studies as evidence of human effects
- Presenting a single study as definitive
- Omitting the study model (just saying "research shows" without saying what kind of research)
- Describing dose and effect without context of how the study was designed
- Extrapolating from one peptide's mechanism to claimed effects of a structurally different peptide
A practical approach
When you encounter a claim about a peptide, find the primary source - the actual published paper, not a summary or blog post about it. Check: what was the model, what was the dose, was there a control group, was it randomised, who conducted and funded it, and has it been replicated? The answers will quickly place the result in its appropriate context.
References: Greenhalgh T. How to Read a Paper: The Basics of Evidence-Based Medicine. 6th ed. Wiley-Blackwell, 2019. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005.
Why study design matters more than results
A result is only as meaningful as the study design that produced it. A 30% body weight reduction in lean mice given high doses by injection tells you something different from a 30% body weight reduction in obese humans in a randomised controlled trial. Both are results. They are not equally meaningful for understanding whether a compound works in humans.
Understanding basic study design elements allows you to place any result in its proper context before drawing conclusions.
The hierarchy of evidence
Research findings are generally ranked by how well a study design controls for confounding factors - things other than the compound being studied that might explain the result.
In vitro studies (cell culture): The lowest level of clinical translation. Cells in a dish behave differently from cells in a living organism with circadian rhythms, immune systems, and dozens of interacting metabolic pathways. Many compounds look promising in cell culture and fail in animals.
Animal studies: More informative than cell culture because they involve a complete organism. However, rodent physiology differs from human physiology in important ways, and dosing in rodents often does not translate directly to humans. Most peptide research is at this stage.
Human case reports and case series: Observations in individual people or small groups. Useful for generating hypotheses but cannot establish causation - many other factors could explain the outcome.
Observational studies in humans: Study groups of people and measure associations. Can establish correlation but not causation. Confounding factors are a persistent problem.
Randomised controlled trials (RCTs): Participants are randomly assigned to receive the compound or a control (placebo or comparator). This randomisation is the only method that controls for unknown confounders. RCTs are the gold standard for establishing efficacy.
Meta-analyses and systematic reviews: Systematically combine multiple studies to estimate overall effect size. Quality depends entirely on the quality and consistency of the underlying studies.
Key questions to ask about any peptide study
What model was used? In vitro, animal (which species), or human?
What was the dose and route? A dose effective subcutaneously in rats may be impractical or irrelevant in humans. Very high doses in animals can produce effects that would never be achievable safely in humans.
Was there a control group? Without a comparison group, it is impossible to know whether the outcome was caused by the compound or something else (time, other interventions, placebo effect).
Was it randomised and blinded? Randomisation prevents selection bias. Blinding prevents expectation bias from influencing outcomes.
Who funded the study? Industry-funded studies are not automatically invalid, but funding source is relevant context. Independent replication is the check on any result, regardless of funder.
Has it been replicated? A single study - regardless of how well designed - is not sufficient to establish a finding. Replication by independent groups is the mechanism by which scientific findings are verified.
Red flags in peptide marketing
Certain patterns in how research is presented should prompt skepticism:
- Citing animal or cell studies as evidence of human effects
- Presenting a single study as definitive
- Omitting the study model (just saying "research shows" without saying what kind of research)
- Describing dose and effect without context of how the study was designed
- Extrapolating from one peptide's mechanism to claimed effects of a structurally different peptide
A practical approach
When you encounter a claim about a peptide, find the primary source - the actual published paper, not a summary or blog post about it. Check: what was the model, what was the dose, was there a control group, was it randomised, who conducted and funded it, and has it been replicated? The answers will quickly place the result in its appropriate context.
References: Greenhalgh T. How to Read a Paper: The Basics of Evidence-Based Medicine. 6th ed. Wiley-Blackwell, 2019. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005.
